sulforaphane has been researched along with Cerebral Ischemia in 3 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Excerpt | Relevance | Reference |
---|---|---|
"Sulforaphane treatment significantly reduced infarct volume and improved neurological scores when compared to a vehicle-treated group." | 5.46 | Sulforaphane improves outcomes and slows cerebral ischemic/reperfusion injury via inhibition of NLRP3 inflammasome activation in rats. ( He, Q; Hou, YH; Li, LY; Song, FZ; Yu, C; Zheng, J, 2017) |
" This study aims to test whether sulforaphane (Sfn), a natural activator of nuclear factor erythroid 2-related factor 2 (Nrf2), reduces the chronic ischemic injury and cognitive dysfunction after VCI." | 3.91 | Protective effects of sulforaphane in experimental vascular cognitive impairment: Contribution of the Nrf2 pathway. ( Gao, Y; Lei, X; Li, X; Mao, L; Sun, B; Sun, Y; Yang, T; Zhang, F; Zhang, W; Zhao, Y, 2019) |
"Sulforaphane treatment significantly reduced infarct volume and improved neurological scores when compared to a vehicle-treated group." | 1.46 | Sulforaphane improves outcomes and slows cerebral ischemic/reperfusion injury via inhibition of NLRP3 inflammasome activation in rats. ( He, Q; Hou, YH; Li, LY; Song, FZ; Yu, C; Zheng, J, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mao, L | 1 |
Yang, T | 1 |
Li, X | 1 |
Lei, X | 1 |
Sun, Y | 1 |
Zhao, Y | 1 |
Zhang, W | 1 |
Gao, Y | 1 |
Sun, B | 1 |
Zhang, F | 1 |
Yu, C | 1 |
He, Q | 1 |
Zheng, J | 1 |
Li, LY | 1 |
Hou, YH | 1 |
Song, FZ | 1 |
Zhao, J | 1 |
Kobori, N | 1 |
Aronowski, J | 1 |
Dash, PK | 1 |
3 other studies available for sulforaphane and Cerebral Ischemia
Article | Year |
---|---|
Protective effects of sulforaphane in experimental vascular cognitive impairment: Contribution of the Nrf2 pathway.
Topics: Animals; Brain; Brain Ischemia; Cell Death; Chronic Disease; Claudin-5; Cognitive Dysfunction; Endot | 2019 |
Sulforaphane improves outcomes and slows cerebral ischemic/reperfusion injury via inhibition of NLRP3 inflammasome activation in rats.
Topics: Animals; Anti-Inflammatory Agents; Brain Ischemia; Brassicaceae; Caspase 1; Down-Regulation; Humans; | 2017 |
Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents.
Topics: Analysis of Variance; Animals; Blotting, Northern; Brain Infarction; Brain Ischemia; Disease Models, | 2006 |